Use of FibroScan? with Controlled Attenuation Parameter to Estimate the Prevalence of NAFLD with Advanced Fibrosis in Patients with or without Metabolic Syndrome
-
- STATUS
- Not Recruiting
Summary
The purpose of this study are to prospectively estimate the prevalence of NAFLD with or without advanced fibrosis in patients with or without metabolic syndrome using FibroScan? with CAP and to examine the relationship between hepatic steatosis measured using CAP and steatosis graded by liver histology and with actual measurement of hepatic triglyceride content in patients where liver histology is available.
Description
The purpose of this study are to prospectively estimate the prevalence of NAFLD with or without advanced fibrosis in patients with or without metabolic syndrome using FibroScan? with CAP and to examine the relationship between hepatic steatosis measured using CAP and steatosis graded by liver histology and with actual measurement of hepatic triglyceride content in patients where liver histology is available.
Details
| Condition | NAFLD |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX6593 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.